Dizziness and Lightheadedness on GLP-1 Medications

Key Points

• Vomiting, diarrhea, and difficulty drinking can lead to dehydration and lightheadedness.
• A substantial reduction in food intake may contribute to weakness or a faint feeling, even when blood glucose is not low.
• Hypoglycemia is a particular concern when a GLP-1-based medicine is used with insulin or an insulin secretagogue, including a sulfonylurea.
• Symptoms triggered by standing may reflect an orthostatic blood-pressure change, but a clinician must assess the cause.
• Fainting, neurologic symptoms, chest pain, breathing difficulty, severe headache, or a severe allergic reaction requires urgent evaluation.

Possible Reasons for Dizziness During GLP-1 Treatment

Several factors can overlap. The timing, triggers, accompanying symptoms, other medicines, and recent food and fluid intake help a clinician narrow the possibilities.

Fluid Loss or Dehydration

Nausea, vomiting, and diarrhea are common adverse reactions with GLP-1-based medicines. When fluid losses exceed intake, circulating blood volume can fall. Lightheadedness, thirst, dry mouth, reduced urination, darker urine, weakness, and a faster heartbeat may occur.

This is more than a comfort issue. The current FDA Wegovy label and FDA Zepbound label warn about acute kidney injury due to volume depletion. Both direct clinicians to monitor renal function when adverse reactions could lead to volume depletion, especially when symptoms are significant.

Repeated vomiting or inability to keep fluids down requires prompt same-day medical advice. Confusion, fainting, seizure, inability to swallow safely, minimal or no urination, severe weakness, or suspected severe hypoglycemia requiring another person's help require emergency care.

Eating Much Less Than Usual

GLP-1 treatment can reduce appetite and increase fullness. Some people also limit food because nausea makes eating difficult. A large change in intake can coincide with fatigue, weakness, headache, or lightheadedness.

That does not automatically mean hypoglycemia. A symptom log can help separate possibilities by recording when dizziness occurs in relation to meals, gastrointestinal symptoms, activity, and medication use. Recurrent symptoms should be discussed with the prescriber, particularly when adequate food or fluid intake has become difficult.

Low Blood Sugar and Glucose-Lowering Co-Medications

GLP-1 receptor agonists stimulate insulin release in a glucose-dependent manner, so hypoglycemia risk is generally lower when they are used without medicines that independently lower glucose. The risk changes when treatment includes insulin or an insulin secretagogue such as glipizide, glimepiride, glyburide, or another sulfonylurea.

FDA labels for Wegovy and Zepbound warn that combining these treatments with insulin or an insulin secretagogue may increase the risk of hypoglycemia, including severe hypoglycemia. The National Institute of Diabetes and Digestive and Kidney Diseases lists shakiness, hunger, tiredness, dizziness or lightheadedness, confusion, headache, and a fast or irregular heartbeat among possible low-glucose symptoms.

People who have a clinician-provided glucose monitoring and hypoglycemia plan should follow that plan. Medication doses should not be changed independently. A prescriber may need to review insulin or secretagogue treatment when glucose readings or symptoms suggest lows.

A Blood-Pressure Drop When Standing

Lightheadedness that starts after getting out of bed, rising from a chair, or standing for several minutes may have an orthostatic pattern. The National Heart, Lung, and Blood Institute describes orthostatic hypotension as low blood pressure that occurs after standing from a sitting or lying position.

Reduced fluid volume can contribute, as can blood-pressure medicines, diuretics, heart conditions, autonomic disorders, and other factors. Wegovy trials reported adverse reactions related to hypotension, including orthostatic hypotension and decreased blood pressure; some events were associated with gastrointestinal adverse reactions and volume loss. The label also notes that hypotension was more frequent among participants taking antihypertensive therapy.

A clinician can decide whether seated and standing blood pressure and pulse measurements, laboratory testing, or a medication review are appropriate. Home readings may provide context, but they do not establish a diagnosis by themselves.

Other Causes Not Specific to GLP-1 Treatment

Inner-ear disorders, viral illness, anemia, abnormal heart rhythms, migraine, pregnancy, medication effects, and neurologic conditions can also cause dizziness. A spinning sensation with head movement differs from feeling faint after standing, and both differ from imbalance while walking.

A symptom should not be attributed to a GLP-1 medicine solely because it began during treatment. New, persistent, recurrent, or worsening dizziness deserves clinical assessment.

Details That Help a Prescriber Evaluate the Symptom

Useful observations include:

• whether the feeling is faintness, spinning, imbalance, or general weakness;
• when it began and how long each episode lasts;
• whether it follows standing, an injection, a meal, exercise, vomiting, or diarrhea;
• recent changes in food and fluid intake;
• glucose readings when monitoring has already been prescribed;
• blood-pressure and pulse readings, if available;
• every prescription medicine, over-the-counter product, and supplement being used; and
• associated symptoms such as hearing changes, headache, palpitations, fever, abdominal pain, or bleeding.

This information can help the prescriber determine whether the next step is a medication review, physical examination, glucose assessment, blood-pressure evaluation, or targeted testing. There is no single test that explains every case of dizziness.

Reducing Immediate Fall Risk

During an episode, sitting or lying down can reduce the chance of a fall. Driving, climbing, and operating equipment are unsafe while dizzy. Standing slowly and using stable support may help until the symptom passes, but these measures do not replace evaluation when episodes recur.

People with ongoing vomiting or diarrhea should contact their care team for guidance on fluid intake and medication management. Fluid advice may need to be modified for kidney disease, heart failure, or another condition that limits intake, so a fixed fluid target is not appropriate for everyone.

When to Contact a Clinician Soon

Contact the prescriber or another clinician promptly when:

• dizziness is new, recurrent, worsening, or interfering with normal activities;
• it repeatedly occurs after standing;
• vomiting, diarrhea, or low intake is continuing;
• glucose readings are below the range in an established diabetes plan;
• blood-pressure readings are unusually low for that person;
• there is a fall, near-fainting, or medication error; or
• symptoms began after a medicine was added or changed.

The prescriber may review the GLP-1 medicine along with insulin, sulfonylureas, blood-pressure medicines, diuretics, and other treatments. Do not stop or adjust prescription medicines without medical guidance unless an emergency clinician instructs otherwise.

Urgent and Emergency Red Flags

Call emergency services for dizziness with:

• new facial droop, one-sided weakness or numbness, trouble speaking, confusion, or loss of coordination;
• a sudden severe headache, seizure, or loss of consciousness;
• chest pain, severe shortness of breath, or a sustained irregular or very rapid heartbeat;
• fainting, especially during exertion or with injury;
• vomiting blood, black stools, or other significant bleeding;
• persistent vomiting with confusion, minimal urination, or severe weakness;
• suspected severe hypoglycemia requiring another person's help, inability to swallow safely, or a prescribed glucagon emergency plan; or
• swelling of the face, lips, tongue, or throat, trouble breathing or swallowing, or widespread hives.

MedlinePlus also advises emergency evaluation when dizziness occurs with weakness, inability to move an arm or leg, vision or speech changes, fainting, chest pain, shortness of breath, head injury, fever with a stiff neck, or ongoing vomiting. See its dizziness aftercare guidance for the full list.

The Bottom Line

Dizziness during GLP-1 treatment can reflect medication adverse effects, dehydration, reduced intake, hypoglycemia from glucose-lowering co-medications, an orthostatic blood-pressure change, or an unrelated condition. The pattern matters. Recording triggers and accompanying symptoms gives a prescriber more useful information than treating every episode as the same problem.

Emergency red flags require immediate care. Recurrent or worsening symptoms warrant a timely medication and health review rather than an independent dose change.

Frequently Asked Questions

Can GLP-1 medications cause dizziness?

Dizziness is listed as an adverse reaction in FDA prescribing information for some GLP-1-based medications. The symptom may also be related to vomiting, diarrhea, reduced fluid or food intake, low blood sugar from another diabetes medicine, or a drop in blood pressure when standing.

Does dizziness on a GLP-1 mean low blood sugar?

Not necessarily. GLP-1-based medicines have a higher hypoglycemia risk when used with insulin or an insulin secretagogue such as a sulfonylurea. Dehydration, low blood pressure, reduced intake, and unrelated conditions can also cause dizziness.

What is orthostatic lightheadedness?

Orthostatic lightheadedness begins or worsens after standing up. It can occur when blood pressure falls with a position change. A clinician can assess the pattern with a medication review, symptoms, and properly timed blood-pressure and pulse measurements.

When is dizziness an emergency?

Repeated vomiting or inability to keep fluids down requires prompt same-day medical advice. Seek emergency care for dizziness with trouble speaking, new weakness or numbness, severe headache, chest pain, trouble breathing, fainting, seizure, inability to swallow safely, significant bleeding, a severe allergic reaction, or suspected severe hypoglycemia requiring another person's help.

Sources

• FDA. Wegovy (semaglutide) Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s033lbl.pdf
• FDA. Zepbound (tirzepatide) Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/217806s031lbl.pdf
• FDA. Ozempic (semaglutide) Prescribing Information: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
• National Heart, Lung, and Blood Institute. Low Blood Pressure: https://www.nhlbi.nih.gov/health/low-blood-pressure
• National Institute of Diabetes and Digestive and Kidney Diseases. Low Blood Glucose (Hypoglycemia): https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia
• MedlinePlus. Dizziness and Vertigo—Aftercare: https://medlineplus.gov/ency/patientinstructions/000692.htm